Saturday 18 May, 2024 12:17 PM
Site map | Locate Us | Login
   Bharat Dynamics Ltd leads gainers in 'A' group    RVNL rises after PAT climbs 33% to Rs 478 cr in Q4 FY24    Volumes spurt at Balkrishna Industries Ltd counter    Go Fashion inks franchise agreement with UAE-based Apparel Group    Bandhan Bank Q4 PAT plunges 93% to Rs 55 cr    Real Estate shares gain    Capital Goods shares gain    Industrials shares gain    Rail Vikas Nigam Ltd Spurts 4.39%, S&P BSE India Infrastructure index Gains 1%    Dr Reddy?s Lab Andhra Pradesh facility gets 2 USFDA observations    Go Digit General Insurance IPO subscribed 9.60 times    JSW Steel Q4 PAT drops 65% YoY to Rs 1,332 cr; declares dividend of Rs7.30/ share    GSK Pharma spurts as Q4 PAT jumps 47% YoY; declares dividend of Rs 32/share    GPT Infra hits life high as Q4 PAT jumps 55% YoY; declares 1:1 bonus issue    Dhanuka Agritech slips after Q4 PAT slides 10% YoY to Rs 59 cr 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Aurobindo Pharma's Rajasthan-based facility concludes US FDA audit with 7 observations
04-May-24   14:38 Hrs IST

The inspection was conducted from 25th April 2024 to 3rd May 2024. The inspection closed with 7 observations.

The observations are procedural in nature and will be responded to within the stipulated time,? Aurobindo Pharma said in a statement.

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

The drug maker reported 90.58% jump in consolidated net profit to Rs 936.29 crore on 13.82% rise in revenue from operations to Rs 7,271.23 crore in Q3 FY24 over Q3 FY23.

The scrip had lost 0.10% to end at Rs 1152.70 on the BSE on Friday.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 32668527
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd